Loading tape…Loading tape…
DVA
DVA
Indices, commodities, movers, heatmap, and top stories. No login required.
Indices, commodities, movers, heatmap, and top stories. No login required.
DVA
DVA NYSE
DaVita is featured in recent reports as Zacks notes 'DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors'. Fundamentally, the company holds a market capitalization of $11.81 billion and reported full-year revenue of $13.64 billion. DaVita also displays a P/E ratio of 15.82, an EPS TTM of 13.08, and a free cash flow yield of 13.63%.
Based on zacks.comDaVita Inc. $DVA Position Lifted by CWA Asset Management Group LLC
DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call
18,685 DaVita Inc. $DVA Shares Acquired by Counterpoint Mutual Funds LLC
DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today
DaVita: After A 25% Drop, The Buyback Machine Is Cheap Again
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.